학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,984건 | 목록 1~20
Editorial & Opinion
van Sinderen N; Department I of Internal Medicine Faculty of Medicine and University Hospital of Cologne Cologne Germany.; JACIE QM Committee Barcelona Spain.; Dolva J; JACIE QM Committee Barcelona Spain.; Hematology Department Oslo University Hospital Oslo Norway.; Riillo C; Department of Hematology University Medical Centre Utrecht Utrecht The Netherlands.; Espada R; JACIE QM Committee Barcelona Spain.; European Society for Blood and Marrow Transplantation (EBMT) Barcelona Spain.; Scheid C; Department I of Internal Medicine Faculty of Medicine and University Hospital of Cologne Cologne Germany.; van Dorp S; Department of Hematology Radboud University Medical Centre Nijmegen The Netherlands.; Nijziel M; Department of Hematooncology Catharina Hospital Eindhoven The Netherlands.; Jak M; Department of Hematology University Medical Centre Utrecht Utrecht The Netherlands.; Malard F; Department of Clinical Hematology and Cellular Therapy Saint-Antoine Hospital, AP-HP Sorbonne University Paris France.; CTIWP, European Society for Blood and Marrow Transplantation (EBMT) Barcelona Spain.; Chabannon C; GoCart Coalition Den Haag, Leiden The Netherlands.; Department of Cellular Therapy Institut Paoli-Calmettes Comprehensive Cancer Centre and Module Biothérapies du Centre d'Investigations Cliniques de Marseille Marseille France.; Egan A; European Society for Blood and Marrow Transplantation (EBMT) Barcelona Spain.; GoCart Coalition Den Haag, Leiden The Netherlands.; Bonini C; GoCart Coalition Den Haag, Leiden The Netherlands.; Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Disease Università Vita-Salute and IRCCS San Raffaele Scientific Institute Milano Italy.; Delgado J; GoCart Coalition Den Haag, Leiden The Netherlands.; Department of Hematology Hospital Clínic, FRCB-IDIBAPS University of Barcelona Barcelona Spain.; Dreyling M; GoCart Coalition Den Haag, Leiden The Netherlands.; Department of Medicine III LMU Hospital Munich Germany.; Ruggeri A; CTIWP, European Society for Blood and Marrow Transplantation (EBMT) Barcelona Spain.; GoCart Coalition Den Haag, Leiden The Netherlands.; Hematology and Bone Marrow Transplantation Unit San Raffaele Scientific Institute Milan Italy.; Subklewe M; GoCart Coalition Den Haag, Leiden The Netherlands.; Department of Medicine III LMU Hospital Munich Germany.; Sureda A; GoCart Coalition Den Haag, Leiden The Netherlands.; Clinical Hematology Department Institut Català d'Oncologia - L'Hospitalet, IDIBELL Universitat de Barcelona Barcelona Spain.; Cabrerizo Y; GoCart Coalition Den Haag, Leiden The Netherlands.; The European Hematology Association The Hague The Netherlands.; Yakoub-Agha I; Cellular Therapy Unit CHU de Lille, Univ Lille, INSERM U1286, Infinite Lille France.; Rintala T; European Society for Blood and Marrow Transplantation (EBMT) Barcelona Spain.; GoCart Coalition Den Haag, Leiden The Netherlands.; JACIE Working Party Barcelona Spain.; Manson L; JACIE Working Party Barcelona Spain.; SNBTS Department of Transfusion Medicine Royal Infirmary of Edinburgh Edinburgh United Kingdom.; Anderson L; Stem Cell Transplant Unit Southampton University Hospital Southampton United Kingdom.; Urbain O; Clinique Universitaire St. Luc Bruxelles Belgium.; Luke R; BMT Unit Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne United Kingdom.; Brandt Kristensen L; Department of Haematology Aarhus University Hospital Aarhus Denmark.; Emmett A; JACIE QM Committee Barcelona Spain.; Blood, Cells and Cancer Division Great Ormond Street Hospital for Children London United Kingdom.; Kuball J; Department of Hematology University Medical Centre Utrecht Utrecht The Netherlands.; CTIWP, European Society for Blood and Marrow Transplantation (EBMT) Barcelona Spain.; GoCart Coalition Den Haag, Leiden The Netherlands.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Ruggeri A.de Wreede L. C.Muller C. R.Crivello P.Bonneville E. F.Petersdorf E. W.Socie G.Dubois V.Niittyvuopio R.Perasaari J.Yakoub-Agha I.Cornelissen J. J.Wieten L.Gedde-Dahl T.Forcade E.Crawley C. R.Marsh S. G. E.Gandemer V.Tholouli E.Bulabois C. -E.Huynh A.Choi G.Deconinck E.Itala-Remes M.Lenhoff S.Bengtsson M.Johansson J. -E.van Gorkom G.Hoogenboom J. D.Vago L.Rocha V.Bonini C.Chabannon C.Fleischhauer K.Clausen J.Holter W.Kalhs P.Beguin Y.Bron D.Deeren D.Lung W. K.Kerre T.Poire X.Selleslag D.Schroyens W.Jindra P.Mayer J.Vydra J.Zak P.Nielsen B.Sengeloev H.Kaare A.Partanen A.Bay J.Bertrand Y.Blaise D.Bourhis J. H.Chevallier P.Cluzeau T.Damaj G.Fegueux N.Guyotat D.Hunault-Berger M.Labussiere-Wallet H.Leleu X.Lioure B.Maury S.Michel G.Mohty M.Rubio M. T.Tilly H.Turlure P.Bethge W.Casper J.Einsele H.Ganser A.Kroger N.Martin S.Platzbecker U.Reinhardt C.Schafer-Eckart K.Thurner L.Valerius T.Wulf G. G.Karakasis D.Spyridonidis A.Hauser P.Remenyi P.Reykdal S.Mousavi A.Angelucci E.Arcese W.Benedetti F.Bernasconi P.Biondi A.Bonifazi F.Carella A. M.Carluccio P.Casini M.Cavanna L.Ciceri F.Cimino G.Corradini P.Fanin R.Galieni P.Grillo G.Iori A. P.La Nasa G.Locatelli F.Marotta G.Martino M.Mazza P.Mordini N.Musso M.Olivieri A.Pavone V.Pane F.Petrini M.Pioltelli P.Rambaldi A.Ruggeri M.Saccardi R.Santarone S.Scime R.Sica S.Tarella C.Velardi A.Visani G.Zecca M.Tanase A.Kulagin A.Savchenko V.Lopez C. A.Amor A. A.Lopez J. L. B.Caballero D.Duarte R.Cascon M. J. P.Porras R. P.Perez-Simon J. A.Rovira M.Sanz J.Carrete J. P. T.Cammenga J.Isaksson C.Mielke S.Chalandon Y.Passweg J.Schanz U.Meijer E.Kuball J.Veelken J. H.Apperley J.Bloor A.Byrne J.Carpenter B.Clark A.Collin M.Craddock C.Gibson B. E.Khan A.Martin M.Medd P.Nicholson E.Orchard K.Patel A.Peniket A.Potter V.Snowden J.Wilson K. M. O.
Haematologica
Haematologica, Vol 108, Iss 2 (2022)
Book
The EBMT Handbook ISBN: 9783031440793
Sureda, Anna; Corbacioglu, Selim; Greco, Raffaella (ed.), The EBMT Handbook
Academic Journal
Hayden, P J, Roddie, C, Bader, P, Basak, G W, Bonig, H, Bonini, C, Chabannon, C, Ciceri, F, Corbacioglu, S, Ellard, R, Sanchez-Guijo, F, Jäger, U, Hildebrandt, M, Hudecek, M, Kersten, M J, Köhl, U, Kuball, J, Mielke, S, Mohty, M, Murray, J, Nagler, A, Rees, J, Rioufol, C, Saccardi, R, Snowden, J A, Styczynski, J, Subklewe, M, Thieblemont, C, Topp, M, Ispizua, U, Chen, D, Vrhovac, R, Gribben, J G, Kröger, N, Einsele, H & Yakoub-Agha, I 2022, 'Management of adults and children receiving CAR T-cell therapy : 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)', Annals of Oncology, vol. 33, no. 3, pp. 259-275. https://doi.org/10.1016/j.annonc.2021.12.003
Academic Journal
Marton C; CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille, France. chrystel.marton@chu-lille.fr.; Clémenceau B; Unité de Thérapie Cellulaire et Génique (UTCG), CHU de Nantes, Nantes, France.; Dachy G; Hematology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Demerle C; Centre de Thérapie Cellulaire, Institut Paoli-Calmettes (IPC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, Inserm CBT-1409 / Aix-Marseille Université / AP-HM / IPC, Marseille, France.; Derenne S; Etablissement Français du Sang, La Plaine Saint Denis, Saint-Denis, France.; Ferrand C; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000, Besançon, France.; Giverne C; CHU de Rouen, Laboratoire d'Immunologie et de Biothérapies, Université de Rouen Normandie, Inserm, UMR 1234, F-76000, Rouen, France.; Latouche JB; Univ Rouen Normandie, Inserm, UMR 1234, CHU de Rouen, Department of Immunology and Biotherapy, F-76000, Rouen, France.; Lemée L; CHU de Rouen, Department of Virology, F-76000, Rouen, France.; Martinet J; Univ Rouen Normandie, Inserm, UMR 1234, CHU de Rouen, Department of Immunology and Biotherapy, F-76000, Rouen, France.; Bonig H; Goethe University, Faculty of Medicine, Institute for Transfusion Medicine and Immunohematology, Frankfurt a.M, Germany.; Bensoussan D; CHRU de Nancy, Unité de Thérapie cellulaire et Banque de Tissus (UTCT). Université de Lorraine, UMR 7365 IMoPA, Vandoeuvre-les-Nancy, France.; Chabannon C; Centre de Thérapie Cellulaire, Institut Paoli-Calmettes (IPC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, Inserm CBT-1409 / Aix-Marseille Université / AP-HM / IPC, Marseille, France.; Köhl U; Fraunhofer Institute for Cell Therapy and Immunology as well as Institute for Clinical Immunology, University of Leipzig, Leipzig, Germany.; Deschamps M; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000, Besançon, France.; De Vos J; Department of Cell and Tissue Engineering, University Montpellier, CHU Montpellier, F-34000, Montpellier, France.; Diana JS; APHP, Hôpital Universitaire Necker Enfants Malades, Centre d'Investigation Clinique en Biothérapie, Laboratoire de Thérapie Cellulaire et Génique, Paris, France.; Dougé A; CHU de Clermont-Ferrand, Service Oncologie médicale, EA 7453 Chelter Université Clermont Auvergne, 63000, Clermont-Ferrand, France.; Forcade E; CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire, UMR 5164, F-33000, Bordeaux, France.; Galaine J; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000, Besançon, France.; Thiant S; Division of hematology, Oncology and transplantation, department of medicine, Maisonneuve-Rosemont hospital, Montréal, QC, Canada.; Galy A; ART-TG, Inserm, US35, 91100, Corbeil-Essonnes, France.; Larghero J; AP-HP, Université Paris Cité, Hôpital Saint-Louis, Centre MEARY de Thérapie Cellulaire et Génique, Unité de Thérapie Cellulaire, Centre d'Investigation Clinique en Biothérapies, Inserm, Paris, France.; Reppel L; CHRU de Nancy, Unité de Thérapie cellulaire et Banque de Tissus (UTCT). Université de Lorraine, UMR 7365 IMoPA, Vandoeuvre-les-Nancy, France.; Viel S; Plateforme de biothérapies - Médicaments de Thérapie Innovante, Hôpital Edouard Herriot, Hospices Civils de Lyon, 69003, Lyon, France.; Boyer O; Univ Rouen Normandie, Inserm, UMR 1234, CHU de Rouen, Department of Immunology and Biotherapy, F-76000, Rouen, France.; Yakoub-Agha I; CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille, France.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Academic Journal
Brugère CA; Institut Carnot CALYM, Paris, France. Electronic address: carole-anne.brugere@calym.org.; Deschaseaux P; Institut Carnot OPALE, Paris, France.; Gomez E; Inatherys, Paris, France.; Roffiaen C; ELLyE, Paris, France.; Brigand T; CERMES3, Villejuif, France.; Esposito G; Blueprint Medicines, Paris, France.; Baruchel A; Hématologie-immunologie pédiatrique, University Hospital Robert-Debré (AP-HP), université de Paris, Paris, France.; Houot R; Department of Hematology, CHU de Rennes, University of Rennes, Inserm U1236, Rennes, France.; Chabannon C; Institut Paoli-Calmettes Comprehensive Cancer Centre, module biothérapies du centre d'investigations cliniques de Marseille, Inserm-Aix-Marseille université-AP-HM-IPC, CBT-1409, Marseille, France.
Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE
Academic Journal
Chartral U; APHP, Hôpital Universitaire Necker Enfants Malades, Centre d'Investigation Clinique en Biothérapie, CIC BT 1416, Laboratoire de Thérapie Cellulaire et Génique, Paris, France.; University Paris Cité, Paris, France.; Galaine J; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.; Giverne C; CHU de Rouen, Laboratoire d'Immunologie et de Biothérapies, Université de Rouen Normandie, INSERM, Rouen, France.; Auxenfans C; Plateforme ARTEMIS, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.; Reppel L; CHRU de Nancy, Unité de Thérapie cellulaire et Banque de Tissus (UTCT). Université de Lorraine, Vandoeuvre-les-Nancy, France.; Marton C; CHU Lille, Univ. Lille, INSERM, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Thiant S; Division of hematology, Oncology, and transplantation, department of medicine, Maisonneuve-Rosemont hospital, Montréal, Québec, Canada.; Clémenceau B; Unité de Thérapie Cellulaire et Génique (UTCG), CHU de Nantes, Nantes, France.; Derenne S; EFS, La Plaine Saint Denis, France.; Sabatier F; Laboratoire de Culture et Thérapie cellulaire (LCTC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM CBT-1409 / Aix-Marseille Université/AP-HM, Marseille, France.; Veran J; Laboratoire de Culture et Thérapie cellulaire (LCTC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM CBT-1409 / Aix-Marseille Université/AP-HM, Marseille, France.; Moisan A; Cell Therapy and Engineering Unit, EFS Rhône Alpes, Saint Ismier, France.; Rouard H; EFS Ile-de-France, Ivry-sur-Seine, France.; Tertrais K; EFS Centre Pays de la Loire, Saint-Herblain, France.; Dachy G; Hematology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Demerle C; Centre de Thérapie Cellulaire, Institut Paoli-Calmettes (IPC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM CBT-1409 / Aix-Marseille Université / AP-HM /IPC, Marseille, France.; Calmels B; Centre de Thérapie Cellulaire, Institut Paoli-Calmettes (IPC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM CBT-1409 / Aix-Marseille Université / AP-HM /IPC, Marseille, France.; Chabannon C; Centre de Thérapie Cellulaire, Institut Paoli-Calmettes (IPC) & module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM CBT-1409 / Aix-Marseille Université / AP-HM /IPC, Marseille, France.; Forcade E; CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire, CNRS UMR 5164, Bordeaux, France.; Viel S; Plateforme ARTEMIS, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.; Bensoussan D; CHRU de Nancy, Unité de Thérapie cellulaire et Banque de Tissus (UTCT). Université de Lorraine, Vandoeuvre-les-Nancy, France.; de Vos J; Department of Cell and Tissue Engineering, University Montpellier, CHU Montpellier, Montpellier, France.; Galy A; ART-TG, INSERM, US35, Corbeil-Essonnes, France.; De Oliveira C; AP-HP, Université Paris Cité, Hôpital Saint-Louis, Centre MEARY de Thérapie Cellulaire et Génique, Unité de Thérapie Cellulaire, Centre d'Investigation Clinique en Biothérapies, INSERM, Paris, France.; Boucher H; AP-HP, Université Paris Cité, Hôpital Saint-Louis, Centre MEARY de Thérapie Cellulaire et Génique, Unité de Thérapie Cellulaire, Centre d'Investigation Clinique en Biothérapies, INSERM, Paris, France.; Magrin E; APHP, Hôpital Universitaire Necker Enfants Malades, Centre d'Investigation Clinique en Biothérapie, CIC BT 1416, Laboratoire de Thérapie Cellulaire et Génique, Paris, France.; Fabreguettes JR; AP-HP, Université Paris Cité, Hôpital Saint-Louis, Centre MEARY de Thérapie Cellulaire et Génique, Unité de Thérapie Cellulaire, Centre d'Investigation Clinique en Biothérapies, INSERM, Paris, France.; Cavazzana M; APHP, Hôpital Universitaire Necker Enfants Malades, Centre d'Investigation Clinique en Biothérapie, CIC BT 1416, Laboratoire de Thérapie Cellulaire et Génique, Paris, France.; University Paris Cité, Paris, France.; Larghero J; AP-HP, Université Paris Cité, Hôpital Saint-Louis, Centre MEARY de Thérapie Cellulaire et Génique, Unité de Thérapie Cellulaire, Centre d'Investigation Clinique en Biothérapies, INSERM, Paris, France.; Deschamps M; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.; Martinet J; CHU de Rouen, Laboratoire d'Immunologie et de Biothérapies, Université de Rouen Normandie, INSERM, Rouen, France.; Boyer O; CHU de Rouen, Laboratoire d'Immunologie et de Biothérapies, Université de Rouen Normandie, INSERM, Rouen, France.; Ferrand C; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.; Yakoub-Agha I; CHU Lille, Univ. Lille, INSERM, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.; Diana JS; APHP, Hôpital Universitaire Necker Enfants Malades, Centre d'Investigation Clinique en Biothérapie, CIC BT 1416, Laboratoire de Thérapie Cellulaire et Génique, Paris, France. Jean-sebastien.diana@aphp.fr.; University Paris Cité, Paris, France. Jean-sebastien.diana@aphp.fr.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Academic Journal
Mahalatchimy A; UMR 7318 International, Comparative and European laws (DICE) CERIC, CNRS, Aix Marseille Université, Aix-en-Provence, France. Electronic address: aurelie.mahalatchimy@univ-amu.fr.; Roby V; UMR 7318 International, Comparative and European laws (DICE) CERIC, CNRS, Aix Marseille Université, Aix-en-Provence, France.; Véran J; Unité de thérapie cellulaire et médicaments de thérapie innovante, Assistance publique-hôpitaux de Marseille & module Biothérapies du Centre d'Investigations Cliniques de Marseille, Inserm CBT_1409_ AMU_ AP-HM_ IPC, Marseille, France.; Chabannon C; Centre de Thérapie Cellulaire. Institut Paoli-Calmettes Comprehensive Cancer Center & module Biothérapies du Centre d'Investigations Cliniques de Marseille, Inserm CBT-1409_ AMU_ AP-HM- IPC, Marseille, France.; Sabatier F; Unité de thérapie cellulaire et médicaments de thérapie innovante, Assistance publique-hôpitaux de Marseille & module Biothérapies du Centre d'Investigations Cliniques de Marseille, Inserm CBT_1409_ AMU_ AP-HM_ IPC, Marseille, France; Center for Cardiovascular Research, C2VN AMU Inserm 1263 INRAe 1260, Marseille, France.
Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Chabannon C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어